A Phase 1 Trial of Riluzole in Spinal Muscular Atrophy
- 1 November 2003
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 60 (11) , 1601-1603
- https://doi.org/10.1001/archneur.60.11.1601
Abstract
Research from JAMA Neurology — A Phase 1 Trial of Riluzole in Spinal Muscular AtrophyKeywords
This publication has 6 references indexed in Scilit:
- Dose-ranging study of riluzole in amyotrophic lateral sclerosisThe Lancet, 1996
- The natural history of type I (severe) spinal muscular atrophyNeuromuscular Disorders, 1994
- The natural history of severe spinal muscular atrophy — Further evidence for clinical subtypesNeuromuscular Disorders, 1994
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Epidemiology of Spinal Muscular Atrophies in a Sample of the Italian PopulationNeuroepidemiology, 1992
- 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission—II Biochemical propertiesNeuropharmacology, 1985